Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC

Описание к видео Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC

Chair and Moderator, Lynette M. Sholl, MD, Pasi A. Jänne, MD, PhD, and Lauren L. Ritterhouse, MD, PhD, discuss NSCLC in this CME/MOC/CC activity titled “Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC information, and to apply for credit, please visit us at PeerView.com/KPW865. CME/MOC/CC credit will be available until November 28, 2022.

Комментарии

Информация по комментариям в разработке